Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 147 articles: HTML format

Single Articles

April 2024
1. HATTER L, Holliday M, Eathorne A, Bruce P, et al
   The carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis.
   Eur Respir J. 2024 Apr 12:2301705. doi: 10.1183/13993003.01705-2023.
   PubMed     Abstract available
   
   
   
2. JACKSON DJ, Pelaia G, Emmanuel B, Tran TN, et al
   Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
   Eur Respir J. 2024 Apr 4:2301521. doi: 10.1183/13993003.01521-2023.
   PubMed     Abstract available
   
   
   
3. KRISHNAN JA, Buhl R
   As-needed ICS/formoterol or as-needed SABA in mild asthma?
   Eur Respir J. 2024;63:2302308.
   PubMed    
   
   
   
4. PAPI A, Ferreira DS, Tonia T, Schleich F, et al
   Response from the authors: As-needed ICS/formoterol or as-needed SABA in mild asthma?
   Eur Respir J. 2024;63:2400395.
   PubMed    
   
   
   
5. STANESCU C, Talarico R, Weichenthal S, Villeneuve PJ, et al
   Early life exposure to pollens and increased risks of childhood asthma: a prospective cohort study in Ontario children.
   Eur Respir J. 2024;63:2301568.
   PubMed     Abstract available
   
   
   
6. VARRICCHI G, Brightling CE, Grainge C, Lambrecht BN, et al
   Airway remodelling in asthma and the epithelium: on the edge of a new era.
   Eur Respir J. 2024;63:2301619.
   PubMed     Abstract available
   
   
   March 2024
7. LIU T, Liu S, Rui X, Cao Y, et al
   Gasdermin B, an asthma-susceptibility gene, promotes MAVS-TBK1 signaling and airway inflammation.
   Eur Respir J. 2024 Mar 21:2301232. doi: 10.1183/13993003.01232-2023.
   PubMed     Abstract available
   
   
   
8. RUSSELL RJ, Boulet LP, Brightling CE, Pavord ID, et al
   The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.
   Eur Respir J. 2024 Mar 7:2301397. doi: 10.1183/13993003.01397-2023.
   PubMed     Abstract available
   
   
   
9. 
   "Asthma and incident coronary heart disease: an observational and Mendelian randomisation study." C.A. Valencia-Hernandez, F. Del Greco M, V. Sundaram, et al. Eur Respir J 2023; 62: 2301788.
   Eur Respir J. 2024;63:2351788.
   PubMed    
   
   
   
10. 
    "Aberrant anti-viral response of natural killer cells in severe asthma." J. Devulder, C. Chenivesse, V. Ledroit, et al. Eur Respir J 2020; 55: 1802422.
    Eur Respir J. 2024;63:1852422.
    PubMed    
    
    
    February 2024
11. WANG T, Duan W, Jia X, Huang X, et al
    Associations of combined phenotypic ageing and genetic risk with incidence of chronic respiratory diseases in the UK Biobank: a prospective cohort study.
    Eur Respir J. 2024;63:2301720.
    PubMed     Abstract available
    
    
    January 2024
12. ZHU Z
    Early-life airway microbiome and childhood asthma development.
    Eur Respir J. 2024;63:2302187.
    PubMed    
    
    
    
13. HOGMAN M, Bowerman C, Chavez L, Dressel H, et al
    ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (F (ENO(50)) ).
    Eur Respir J. 2024;63:2300370.
    PubMed     Abstract available
    
    
    
14. 
    ERJ Podcast January 2024: The microbiome in early life and childhood asthma.
    Eur Respir J. 2024;63:24E6301.
    PubMed    
    
    
    December 2023
15. SUNDE RB MD PHD, Thorsen J MD PhD, Kim M MSc PhD, Schoos AM MD PhD, et al
    Bacterial Colonization of the Airway in Neonates and Risk of Asthma and Allergy Until Age 18 Years.
    Eur Respir J. 2023 Dec 14:2300471. doi: 10.1183/13993003.00471-2023.
    PubMed     Abstract available
    
    
    
16. BEASLEY R, Noble J, Weatherall M
    Clinical remission with biologic therapies in severe asthma: a matter of definition.
    Eur Respir J. 2023;62:2301844.
    PubMed    
    
    
    
17. WECKMANN M, Reddy KD
    Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow.
    Eur Respir J. 2023;62:2301552.
    PubMed    
    
    
    November 2023
18. CIVIDINI S, Sinha I, Donegan S, Maden M, et al
    Best step-up treatments for children with uncontrolled asthma: A systematic review and network meta-analysis of individual participant data.
    Eur Respir J. 2023 Nov 9:2301011. doi: 10.1183/13993003.01011-2023.
    PubMed     Abstract available
    
    
    
19. VALENCIA-HERNANDEZ CA, Del Greco M F, Sundaram V, Portas L, et al
    Asthma and incident coronary heart disease: an observational and Mendelian randomisation study.
    Eur Respir J. 2023 Nov 9:2301788. doi: 10.1183/13993003.01788-2023.
    PubMed     Abstract available
    
    
    
20. SORIANO JB, Polverino F
    Sex and gender in COPD and asthma.
    Eur Respir J. 2023;62:2301505.
    PubMed    
    
    
    
21. MORGAN C, Higbee D
    An attack of asthma is not an attack of the heart: clarifying causal links between asthma and incident coronary heart disease.
    Eur Respir J. 2023;62:2302009.
    PubMed    
    
    
    October 2023
22. MCDOWELL PJ, McDowell R, Busby J, Eastwood MC, et al
    Clinical remission in severe asthma with Biologic Therapy: an analysis from the UK Severe Asthma Registry.
    Eur Respir J. 2023 Oct 19:2300819. doi: 10.1183/13993003.00819-2023.
    PubMed     Abstract available
    
    
    
23. HERRERA-LUIS E, de la Rosa-Baez C, Huntsman S, Eng C, et al
    Novel insights into the whole blood DNA methylome of asthma in ethnically diverse children and youth.
    Eur Respir J. 2023 Oct 6:2300714. doi: 10.1183/13993003.00714-2023.
    PubMed     Abstract available
    
    
    
24. 
    October Podcast: ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma.
    Eur Respir J. 2023;62:23E6204.
    PubMed    
    
    
    September 2023
25. FIOCCHI AG, Phipatanakul W, Zeiger RS, Durrani SR, et al
    Dupilumab leads to better-controlled asthma & quality of life in children: the VOYAGE study.
    Eur Respir J. 2023 Sep 21:2300558. doi: 10.1183/13993003.00558-2023.
    PubMed     Abstract available
    
    
    
26. PAPI A, Ferreira DS, Agache I, Baraldi E, et al
    European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma.
    Eur Respir J. 2023 Sep 7:2300047. doi: 10.1183/13993003.00047-2023.
    PubMed     Abstract available
    
    
    
27. FARINHA I, Heaney LG
    Defining trajectory in severe asthma: can it be changed?
    Eur Respir J. 2023;62:2301281.
    PubMed    
    
    
    August 2023
28. VON BULOW A, Hansen S, Sandin P, Ernstsson O, et al
    Severe asthma trajectories in adults: findings from the NORDSTAR cohort.
    Eur Respir J. 2023 Aug 24:2202474. doi: 10.1183/13993003.02474-2022.
    PubMed     Abstract available
    
    
    
29. POWELL WT, Reeves SR
    From small to big, using microRNA profiling to investigate infant origins of childhood asthma.
    Eur Respir J. 2023;62:2301052.
    PubMed    
    
    
    
30. OSADNIK CR, Brighton LJ, Burtin C, Cesari M, et al
    European Respiratory Society statement on frailty in adults with chronic lung disease.
    Eur Respir J. 2023;62:2300442.
    PubMed     Abstract available
    
    
    July 2023
31. CAZZOLA M, Page CP, Matera MG, Rogliani P, et al
    Revisiting Asthma Pharmacotherapy: Where Do We Stand and Where Do We Want to Go?
    Eur Respir J. 2023 Jul 20:2300700. doi: 10.1183/13993003.00700-2023.
    PubMed     Abstract available
    
    
    
32. NANZER AM, Taylor V, Hearn AP, Kavanagh JE, et al
    The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
    Eur Respir J. 2023 Jul 20:2300245. doi: 10.1183/13993003.00245-2023.
    PubMed    
    
    
    June 2023
33. ZHU Z, Freishtat RJ, Harmon B, Hahn A, et al
    Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study.
    Eur Respir J. 2023 Jun 15:2300502. doi: 10.1183/13993003.00502-2023.
    PubMed     Abstract available
    
    
    
34. DUIJTS L
    Prematurity-related chronic respiratory disease across the life course.
    Eur Respir J. 2023;61:2300662.
    PubMed    
    
    
    
35. VAN DER VEER T, de Koning Gans JM, Braunstahl GJ, Pieters A, et al
    The effect of beclomethasone-formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis: the FORZA randomised-controlled trial.
    Eur Respir J. 2023 Jun 1:2300186. doi: 10.1183/13993003.00186-2023.
    PubMed    
    
    
    April 2023
36. EIWEGGER T, Bendien SA
    Defining the questions to be asked in severe asthma trials: data from the COMSA working group.
    Eur Respir J. 2023;61:2202058.
    PubMed    
    
    
    March 2023
37. PULAKKA A, Risnes K, Metsala J, Alenius S, et al
    Preterm birth and asthma and COPD in adulthood: a nationwide register study from two Nordic countries.
    Eur Respir J. 2023 Mar 29:2201763. doi: 10.1183/13993003.01763-2022.
    PubMed     Abstract available
    
    
    
38. MAHMOUD O, Granell R, Peralta GP, Garcia-Aymerich J, et al
    Early-life and health behaviour influences on lung function in early adulthood.
    Eur Respir J. 2023;61:2001316.
    PubMed     Abstract available
    
    
    
39. CHARRIOT J, Ahmed E, Bourdin A
    Local targeting of TSLP: feat or defeat.
    Eur Respir J. 2023;61:2202389.
    PubMed    
    
    
    
40. SCHNEIDER S, Poglitsch K, Morgenstern C, Quint T, et al
    Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
    Eur Respir J. 2023;61:2201335.
    PubMed     Abstract available
    
    
    
41. NOBLE PB, Donovan GM
    If your patient with asthma wheezes when sitting or lying quietly, lung function testing may reveal small airway disease.
    Eur Respir J. 2023;61:2202307.
    PubMed    
    
    
    
42. CORREN J, Brightling CE, Boulet LP, Porsbjerg C, et al
    Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.
    Eur Respir J. 2023;61:2202202.
    PubMed    
    
    
    
43. BOULET LP, Boulay ME, Cote A, FitzGerald JM, et al
    Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry.
    Eur Respir J. 2023;61:2201194.
    PubMed     Abstract available
    
    
    February 2023
44. GAUVREAU GM, Hohlfeld JM, FitzGerald MJ, Boulet LP, et al
    Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Eur Respir J. 2023 Feb 23:2201193. doi: 10.1183/13993003.01193-2022.
    PubMed     Abstract available
    
    
    
45. ABDO M, Kirsten AM, von Mutius E, Kopp M, et al
    Minimal Clinically Important Difference for Impulse Oscillometry in Adults with Asthma.
    Eur Respir J. 2023 Feb 9:2201793. doi: 10.1183/13993003.01793-2022.
    PubMed     Abstract available
    
    
    
46. SAVOURE M, Bousquet J, Leynaert B, Renuy A, et al
    Rhinitis phenotypes and multimorbidities in the general population: the CONSTANCES cohort.
    Eur Respir J. 2023;61:2200943.
    PubMed     Abstract available
    
    
    January 2023
47. POLLOCK J, Chalmers JD
    Aspergillus sensitisation: an underappreciated treatable trait in airway disease.
    Eur Respir J. 2023;61:2202042.
    PubMed    
    
    
    
48. FAWCETT KA
    Seeing the trees for the wood: reducing heterogeneity in genomic studies of asthma.
    Eur Respir J. 2023;61:2201931.
    PubMed    
    
    
    December 2022
49. DAVIES D, Hyland ME, Lanario JW, Jones RC, et al
    Moving towards patient-centred outcomes: the Severe Asthma Questionnaire.
    Eur Respir J. 2022 Dec 30:2202305. doi: 10.1183/13993003.02305-2022.
    PubMed    
    
    
    
50. RATTU A, Khaleva E, Brightling C, Dahlen SE, et al
    Identifying and appraising outcome measures for severe asthma: a systematic review.
    Eur Respir J. 2022 Dec 22:2201231. doi: 10.1183/13993003.01231-2022.
    PubMed     Abstract available
    
    
    
51. KOCKS J, van der Molen T, Voorham J, Baldi S, et al
    Development of a tool to detect small airways dysfunction in asthma clinical practice.
    Eur Respir J. 2022 Dec 14:2200558. doi: 10.1183/13993003.00558-2022.
    PubMed     Abstract available
    
    
    
52. HAHN DL, Webley W
    U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2200571.
    PubMed    
    
    
    
53. SPARREMAN MIKUS M, Kolmert J, Andersson LI, Dahlen SE, et al
    Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2201795.
    PubMed    
    
    
    
54. MENZIES-GOW A, Gurnell M, Heaney LG, Corren J, et al
    Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
    Eur Respir J. 2022;60:2103226.
    PubMed     Abstract available
    
    
    November 2022
55. CHERIAN M, Magner KMA, Whitmore GA, Vandemheen KL, et al
    Patient and physician factors associated with symptomatic undiagnosed asthma or COPD.
    Eur Respir J. 2022 Nov 3. pii: 13993003.01721-2022.
    PubMed     Abstract available
    
    
    
56. BUSSE WW
    Improving systemic corticosteroid stewardship in asthma.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
57. PARK JS, Cho YJ, Yun JY, Lee HJ, et al
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J. 2022;60.
    PubMed     Abstract available
    
    
    
58. PETSKY H
    Randomised controlled trials utilising F ENO to manage asthma: is it time to acknowledge that "one size does not fit all"?
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
59. ROBERTS G
    Is it time to consider allergen immunotherapy earlier in the management of allergic asthma?
    Eur Respir J. 2022;60.
    PubMed    
    
    
    October 2022
60. KHALEVA E, Rattu A, Brightling C, Bush A, et al
    Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
    Eur Respir J. 2022 Oct 13. pii: 13993003.00606-2022.
    PubMed     Abstract available
    
    
    
61. POLVERINO F, Marin JM
    The lower respiratory tract: the hot spot for chronic fixed airflow limitation.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    September 2022
62. PERSSON C
    Creola bodies and pathogenesis of childhood asthma.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01204-2022.
    PubMed    
    
    
    
63. COLEMAN C, Khaleva E, Rattu A, Frankemolle B, et al
    Narrative Review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00837-2022.
    PubMed     Abstract available
    
    
    
64. LIU J, Bowatte G, Pham J, Perret JL, et al
    Pre-pubertal smoke exposure of fathers and increased risk of offspring asthma: a possible transgenerational effect.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00257-2022.
    PubMed    
    
    
    
65. SORIANO JB
    Planetary respiratory health for asthma, rhinoconjunctivitis and eczema.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
66. CHAN JSK, Murray RB, Price D
    Oral corticosteroids in asthma and beyond: moving forward.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
67. PERREM L, Subbarao P
    Moving the dial on identifying endotypes of asthma from early life.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
68. 
    "Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma." M.K. Ali, R.Y. Kim, A.C. Brown et al. Eur Respir J 2020; 55: 1901340.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
69. PAVORD ID
    Case-finding and diagnosis of obstructive airway diseases: the Dragons' Den experience.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    August 2022
70. CHAN R, Lipworth B
    Interactions between spirometry and oscillometry in patients with moderate to severe asthma.
    Eur Respir J. 2022 Aug 18. pii: 13993003.00543-2022.
    PubMed    
    
    
    
71. LEE S, Prokopenko D, Kelly RS, Lutz S, et al
    Zinc finger protein 33B demonstrates sex-interaction with atopy-related markers in childhood asthma.
    Eur Respir J. 2022 Aug 11. pii: 13993003.00479-2022.
    PubMed     Abstract available
    
    
    July 2022
72. PERRET JL, Dharmage SC, Bui DS
    Early life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
    Eur Respir J. 2022 Jul 26. pii: 13993003.01141-2022.
    PubMed    
    
    
    
73. MCLOUGHLIN RF, Clark VL, Urroz PD, Gibson PG, et al
    Increasing physical activity in severe asthma: a systematic review and meta-analysis.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00546-2022.
    PubMed     Abstract available
    
    
    
74. VAN MEEL ER, Duijts L
    Reply to: "Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?"
    Eur Respir J. 2022 Jul 26. pii: 13993003.01384-2022.
    PubMed    
    
    
    
75. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    PubMed     Abstract available
    
    
    
76. REDMOND C, Heaney LG, Chaudhuri R, Jackson DJ, et al
    Benefits of specialist severe asthma management: demographic and geographic disparities.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00660-2022.
    PubMed     Abstract available
    
    
    
77. HOLMES J, McGarvey LP, Birring SS, Fletcher H, et al
    An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
    Eur Respir J. 2022 Jul 1. pii: 13993003.03205-2021.
    PubMed     Abstract available
    
    
    
78. SALTER B, Zhao N, Son K, Suray Tan N, et al
    Airway autoantibodies are determinants of asthma severity.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00442-2022.
    PubMed     Abstract available
    
    
    
79. WURZEL D, Licciardi PV
    Targeted strategies are needed to prevent childhood asthma.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
80. WARK PAB
    We need to understand why viral infections lead to acute asthma.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
81. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
82. COUILLARD S
    The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    June 2022
83. 
    "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343-373.
    Eur Respir J. 2022;59.
    PubMed    
    
    
    
84. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    
    
    
    
85. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    
    
    
    May 2022
86. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed     Abstract available
    
    
    
87. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed     Abstract available
    
    
    
88. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    PubMed     Abstract available
    
    
    
89. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    PubMed     Abstract available
    
    
    
90. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    PubMed     Abstract available
    
    
    
91. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    April 2022
92. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    PubMed    
    
    
    
93. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    PubMed     Abstract available
    
    
    
94. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    
95. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    March 2022
96. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    PubMed     Abstract available
    
    
    
97. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    PubMed     Abstract available
    
    
    
98. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    PubMed     Abstract available
    
    
    
99. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    PubMed    
    
    
    
100. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
     Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
     Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
     PubMed     Abstract available
     
     
     
101. VONK JM, Roukema J
     Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
     Eur Respir J. 2022;59.
     PubMed    
     
     
     
102. THAMRIN C, Robinson PD, Farah CS, King GG, et al
     Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
     Eur Respir J. 2022;59.
     PubMed    
     
     
     
103. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
     Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
     Eur Respir J. 2022;59.
     PubMed     Abstract available
     
     
     February 2022
104. MAISON N, Omony J, Illi S, Thiele D, et al
     T-high asthma phenotypes across life span.
     Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
     PubMed     Abstract available
     
     
     
105. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
     Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
     Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
     PubMed     Abstract available
     
     
     
106. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
     Asthma management in low- and middle-income countries: case for change.
     Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
     PubMed     Abstract available
     
     
     
107. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
     The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
     Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
     PubMed     Abstract available
     
     
     
108. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
     Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
     Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
     PubMed     Abstract available
     
     
     
109. LOUIS R, Satia I, Ojanguren I, Schleich F, et al
     European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.
     Eur Respir J. 2022 Feb 15. pii: 13993003.01585-2021.
     PubMed     Abstract available
     
     
     
110. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
     Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
     Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
     PubMed     Abstract available
     
     
     
111. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
     The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
     Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
     PubMed     Abstract available
     
     
     
112. TAYTARD J, Koskas M, Beydon N
     Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
     Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
     PubMed    
     
     
     
113. MARCON A, Locatelli F, Accordini S
     The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
     Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
     PubMed    
     
     
     
114. KEARNS N, Bruce P, Williams M, Doppen M, et al
     Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.
     Eur Respir J. 2022 Feb 3. pii: 13993003.02309-2021.
     PubMed     Abstract available
     
     
     
115. SEYS SF, Long MB
     The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
     Eur Respir J. 2022;59.
     PubMed    
     
     
     January 2022
116. PARASKAKIS E, Sarikloglou E, Fouzas S, Steiropoulos P, et al
     Improved prediction of asthma exacerbations by measuring distal airway inflammation.
     Eur Respir J. 2022 Jan 27. pii: 13993003.01684-2021.
     PubMed    
     
     
     
117. GAUVREAU GM, Davis BE, Scadding G, Boulet LP, et al
     Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience.
     Eur Respir J. 2022 Jan 27. pii: 13993003.02782-2021.
     PubMed     Abstract available
     
     
     
118. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
     Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
     Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
     PubMed     Abstract available
     
     
     
119. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
     Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
     Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
     PubMed     Abstract available
     
     
     
120. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
     Vulnerability to acid reflux of the airway epithelium in severe asthma.
     Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
     PubMed     Abstract available
     
     
     
121. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
     Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
     Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
     PubMed     Abstract available
     
     
     
122. BENSON VS, Hartl S, Barnes N, Galwey N, et al
     Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
     Eur Respir J. 2022;59.
     PubMed     Abstract available
     
     
     December 2021
123. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
     Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
     Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
     PubMed     Abstract available
     
     
     
124. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
     Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
     Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
     PubMed     Abstract available
     
     
     
125. AGARWAL R, Muthu V
     Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
     Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
     PubMed    
     
     
     
126. HAVETTE A, Regard L, Roche N, Burgel PR, et al
     Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
     Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
     PubMed    
     
     
     
127. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
     Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
     Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
     PubMed     Abstract available
     
     
     
128. GURDENIZ G, Ernst M, Rago D, Kim M, et al
     Neonatal metabolome of cesarean section and risk of childhood asthma.
     Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
     PubMed     Abstract available
     
     
     
129. RYAN D, Sabroe I
     Identifying and addressing health inequalities in asthma care.
     Eur Respir J. 2021;58.
     PubMed    
     
     
     
130. PAPAIOANNOU AI, Photiades A, Gaga M
     Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
     Eur Respir J. 2021;58.
     PubMed    
     
     
     
131. PARK S, Lee S, Kim Y, Cho S, et al
     Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
     Eur Respir J. 2021;58.
     PubMed     Abstract available
     
     
     November 2021
132. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
     A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
     Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
     PubMed    
     
     
     
133. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
     Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
     Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
     PubMed     Abstract available
     
     
     
134. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
     Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
     Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
     PubMed     Abstract available
     
     
     
135. OLIVER BG
     Food for thought: why is there more airway smooth muscle in asthma?
     Eur Respir J. 2021;58.
     PubMed    
     
     
     
136. MANNINO DM
     Asthma, COPD and their overlap: coexistence or something more?
     Eur Respir J. 2021;58.
     PubMed    
     
     
     October 2021
137. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
     Childhood asthma- pathogenesis and phenotypes.
     Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
     PubMed     Abstract available
     
     
     
138. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
     Outcomes over the first two years of treatment with mepolizumab in severe asthma.
     Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
     PubMed     Abstract available
     
     
     
139. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
     Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
     Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
     PubMed     Abstract available
     
     
     
140. CHAN R, Misirovs R, Lipworth B
     Repeatability of impulse oscillometry in patients with severe asthma.
     Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
     PubMed    
     
     
     
141. SUN Y, Xia PF, Xie J, Mustieles V, et al
     Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
     Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
     PubMed     Abstract available
     
     
     
142. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
     3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
     Eur Respir J. 2021;58.
     PubMed    
     
     
     September 2021
143. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
     Accelerated decline in lung function in adults with a history of remitted childhood asthma.
     Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
     PubMed     Abstract available
     
     
     
144. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
     Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
     Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
     PubMed     Abstract available
     
     
     
145. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
     Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
     Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
     PubMed     Abstract available
     
     
     
146. PANAGOU P, Tzilas V, Bouros D
     "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
     Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
     PubMed    
     
     
     April 2021
147. ESTEVES P, Blanc L, Celle A, Dupin I, et al
     Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
     Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.